GLOBALT Investments’s Boston Scientific BSX Stock Holding History

GLOBALT Investments’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-7,980	Closed	-$501K	–	216
2026 Q1	$501K	Sell	7,980 -373	-4%	-$29.8K	0.02%	178
2025 Q4	$796K	Sell	8,353 -878	-10%	-$86.1K	0.03%	145
2025 Q3	$901K	Sell	9,231 -91	-1%	-$9.42K	0.03%	143
2025 Q2	$1M	Buy	9,322 +754	+9%	+$76.3K	0.04%	144
2025 Q1	$864K	Sell	8,568 -781	-8%	-$78.6K	0.04%	149
2024 Q4	$835K	Buy	9,349 +779	+9%	+$68.6K	0.03%	155
2024 Q3	$718K	Buy	+8,570	New	+$676K	0.03%	160

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

California State Teachers Retirement System (CalSTRS) West Sacramento, California $782B AUM 28.39% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

GLOBALT Investments's BSX Position: Q2 2026 in Review

GLOBALT Investments sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 7,980 shares — an estimated $501K sold.

GLOBALT Investments first reported a position in BSX in Q3 2024 and held it in 7 quarters. The position peaked at $1M in Q2 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

GLOBALT Investments reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
GLOBALT Investments sold 7,980 Boston Scientific shares in Q2 2026, an estimated $501K.
GLOBALT Investments first reported a position in Boston Scientific in Q3 2024 and held it in 7 quarters.
GLOBALT Investments's Boston Scientific position peaked at $1M in Q2 2025.
1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on GLOBALT Investments's 13F filing for Q2 2026, filed 11 Aug 2026.